{
    "organizations": [],
    "uuid": "7b055505a97be4891b1fb56e40909f157c3e9be9",
    "author": "",
    "url": "https://www.reuters.com/article/brief-viveve-says-fda-signs-off-on-clini/brief-viveve-says-fda-signs-off-on-clinical-study-idUSASC09SS8",
    "ord_in_thread": 0,
    "title": "BRIEF-Viveve Says FDA Signs Off On Clinical Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 43 PM / Updated 11 minutes ago BRIEF-Viveve Says FDA Signs Off On Clinical Study Reuters Staff March 19 (Reuters) - Viveve Medical Inc: * VIVEVE ANNOUNCES FDA APPROVAL OF IDE TO CONDUCT VIVEVE II CLINICAL STUDY * VIVEVE MEDICAL INC - ‍VIVEVE II CLINICAL TRIAL EXPECTED TO BEGIN IN Q2 2018​ Source text for Eikon:  ",
    "published": "2018-03-19T14:40:00.000+02:00",
    "crawled": "2018-03-19T15:00:07.028+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "say",
        "fda",
        "sign",
        "clinical",
        "study",
        "reuters",
        "staff",
        "march",
        "reuters",
        "viveve",
        "medical",
        "inc",
        "viveve",
        "announces",
        "fda",
        "approval",
        "ide",
        "conduct",
        "viveve",
        "ii",
        "clinical",
        "study",
        "viveve",
        "medical",
        "inc",
        "ii",
        "clinical",
        "trial",
        "expected",
        "begin",
        "q2",
        "source",
        "text",
        "eikon"
    ]
}